Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Sharon Mates
Age : 68
Public asset : 51,762,013 USD
Country of residence : Unknown
Linked companies : Intra-Cellular Therapies, Inc.

Summary 
Founder of Intra-Cellular Therapies, Inc., Functional Genetics, Inc., ITI, Inc. (New York) and Intra-Cellular Therapies, Inc., Sharon Mates is an entrepreneur and businessperson who has been the head of 6 different companies and presently occupies the position of Chairman, President & Chief Executive Officer at Intra-Cellular Therapies, Inc. and Chairman, President & Chief Executive Officer for ITI, Inc. (New York) (a subsidiary of Intra-Cellular Therapies, Inc.). Sharon Mates is also Director-Emerging Company Section at Biotechnology Innovation Organization.

She previously occupied the position of Chairman & Chief Executive Officer of Functional Genetics, Inc., Chairman, President & Chief Executive Officer at Intra-Cellular Therapies, Inc., President & Director at North American Vaccine, Inc., Chairman at New York Biotechnology Association, Inc. and Director-Biotechnology Institute at the University of Maryland.

Dr. Mates received a doctorate from the University of Washington and an undergraduate degree from The Ohio State University.




Current positions of Sharon Mates 
Holdings of Sharon Mates 
Sharon Mates : Personal Network 
Most Read News 
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
12/01Salesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
11/18Musk's pay trial asks if Tesla's growth justifies $56 billion compensation
RE
11/22'Boomerang CEOs' don't always work out; Disney hopes this one bucks trend
RE
11/21Musk says Twitter to hold off relaunching blue check verification
RE
11/19Musk's Twitter poll showing narrow majority want Trump reinstated
RE
More news


© 2022 People and Ownership :   
Sharon Mates : Connections 


Latest news about Sharon Mates 
11/03Transcript : Intra-Cellular Therapies, Inc., Q3 2022 Earnings Call, Nov 03, 2022
CI
08/09Transcript : Intra-Cellular Therapies, Inc., Q2 2022 Earnings Call, Aug 09, 2022
CI
05/10Transcript : Intra-Cellular Therapies, Inc., Q1 2022 Earnings Call, May 10, 2022
CI
03/01Transcript : Intra-Cellular Therapies, Inc., Q4 2021 Earnings Call, Mar 01, 2022
CI
02/24Insider Sell: Intra-Cellular Therapies
MT
01/12Insider Sell: Intra-Cellular Therapies
MT
01/10Transcript : Intra-Cellular Therapies, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 07:30 AM
CI
More news